Evidence map›Paper›PMID 39682258›Full record

ArticleCancers2024

Retrospective-Prospective Observational Study of Italian Patients Treated in Melanoma Adjuvant Cohort MAP-MADAM (Maximing ADjuvAnt MAP): Interim Analysis.

Francesca Consoli, Marco Tucci, Jacopo Pigozzo, Ester Simeone, Francesco Spagnolo, Teresa Troiani, Francesca Morgese, Michele Del Vecchio, Barbara Melotti, Maria Chiara Tronconi and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Francesca ConsoliMedical Oncology, ASST Spedali Civili, 25123 Brescia, Italy.ORCID 0000-0003-0933-8334
Marco TucciMedical Oncology Unit, University of Bari Aldo Moro, Policlinico Hospital of Bari, 70124 Bari, Italy.ORCID 0000-0003-4008-4897
Jacopo PigozzoVeneto Institute of Oncology IOV-IRCCS, 35128 Padova, Italy.ORCID 0000-0003-2427-8915
Ester SimeoneUnit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute G. Pascale, 80131 Naples, Italy.
Francesco SpagnoloDepartment of Medical Oncology, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.
Teresa TroianiMedical Oncology Unit, Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80123 Naples, Italy.ORCID 0000-0002-0646-4901
Francesca MorgeseOncology Clinic, Polytechnic University of Marche, United Hospitals of Ancona, 60126 Ancona, Italy.
Michele Del VecchioS.S. Oncologia Medica Melanomi, S.C. Oncologia Medica 1, Dipartimento di Oncologia Medica ed Ematologia, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Barbara MelottiDivisione di Oncologia Medica, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.ORCID 0000-0003-1041-391X
Maria Chiara TronconiIRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.ORCID 0000-0003-4911-2823
Maria Francesca MorelliOncologia e Oncologia Dermatologica, Istituto Dermopatico dell'Immacolata IDI-IRCCS, 00167 Rome, Italy.
Federica GrossoMesothelioma and Rare Cancers Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, 15121 Alessandria, Italy.ORCID 0000-0002-6843-3369
Barbara MerelliUnit of Medical Oncology, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.ORCID 0009-0000-8535-119X
Ilaria MarconNovartis Farma S.p.A, 20154 Milan, Italy.
Diletta ValsecchiNovartis Farma S.p.A, 20154 Milan, Italy.
Pietro QuaglinoDermatology Clinic, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Funding

Novartis (Italy) NA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvantdabrafenib plus trametinibmelanomarelapse-free survivalstage III

Identifiers

PMID39682258
PMCPMC11640251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.